Medicud
Medicud develops a single-use incisional negative pressure wound therapy (i-NPWT) device called Dryum designed to improve wound healing. The company focuses on creating easy-to-use, discreet, and sustainable medical technologies that reduce therapy costs and ecological footprints compared to traditional absorbent dressings. Their target market includes healthcare providers and patients requiring advanced surgical wound care.
Visit websiteRome, Italy
Healthtech
Medical Devices
Manufacturing
Funding summary
- Total raised
- €1.3M
- Funding rounds
- 1
Investors in Medicud
Investors on record for Medicud. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Medicud?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors